Xvivo Perfusion AB Market Cap

Xvivo Perfusion AB has a market cap or net worth of 8.50 billion as of April 29, 2026. Its market cap has decreased by -1.75% in one year.

Market Cap

8.50B

Enterprise Value

8.32B

Revenue

834.53M

Ranking

n/a

PE Ratio

115.15

Stock Price

276.40

Market Cap Chart

Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 8.50B, an increase of 2,188.14%. That is a compound annual growth rate of 25.96%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	8.50B	44.69%
Dec 30, 2025	5.88B	-61.84%
Dec 30, 2024	15.40B	48.41%
Dec 29, 2023	10.38B	90.12%
Dec 30, 2022	5.46B	-33.55%
Dec 30, 2021	8.22B	-8.90%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
MedCap AB	7.34B
Nolato AB	13.74B
Vitrolife AB	15.71B
Elekta AB	20.90B
CellaVision AB	2.87B
Sectra AB	50.63B
Getinge AB	52.31B
BICO Group AB	1.40B

Market Cap Rankings